Cargando…

Biomarkers of endothelial activation and inflammation in dogs with organ dysfunction secondary to sepsis

INTRODUCTION: Alteration in endothelial function during sepsis is thought to play a key role in the progression of organ failure. We herein compared plasma concentrations of endothelial activation biomarkers vascular endothelial growth factor (VEGF), hyaluronan (HA), plasminogen activator inhibitor-...

Descripción completa

Detalles Bibliográficos
Autores principales: Gaudette, Sarah, Smart, Lisa, Woodward, Andrew P., Sharp, Claire R., Hughes, Dez, Bailey, Simon R., Dandrieux, Julien R. S., Santos, Leilani, Boller, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372490/
https://www.ncbi.nlm.nih.gov/pubmed/37520007
http://dx.doi.org/10.3389/fvets.2023.1127099
_version_ 1785078388496531456
author Gaudette, Sarah
Smart, Lisa
Woodward, Andrew P.
Sharp, Claire R.
Hughes, Dez
Bailey, Simon R.
Dandrieux, Julien R. S.
Santos, Leilani
Boller, Manuel
author_facet Gaudette, Sarah
Smart, Lisa
Woodward, Andrew P.
Sharp, Claire R.
Hughes, Dez
Bailey, Simon R.
Dandrieux, Julien R. S.
Santos, Leilani
Boller, Manuel
author_sort Gaudette, Sarah
collection PubMed
description INTRODUCTION: Alteration in endothelial function during sepsis is thought to play a key role in the progression of organ failure. We herein compared plasma concentrations of endothelial activation biomarkers vascular endothelial growth factor (VEGF), hyaluronan (HA), plasminogen activator inhibitor-1 (PAI-1) and von Willebrand factor (vWF), as well as inflammatory mediator concentrations (IL-6, IL-8, IL-10, C-reactive protein and monocyte chemoattractant protein-1) in dogs with sepsis to healthy dogs. METHODS: This study was a multicenter observational clinical trial conducted at two university teaching hospitals from February 2016 until July 2017. The study included 18 client-owned dogs hospitalized with sepsis and at least one distant organ dysfunction, as well as 20 healthy dogs. Plasma biomarker concentrations were measured using ELISA. Severity of illness in dogs with sepsis was calculated using the 5-variable acute physiologic and laboratory evaluation (APPLE(FAST)) score. Biomarker concentrations were compared between septic and healthy dogs using linear models. RESULTS: Septic peritonitis was the most frequent source of sepsis (11/18; 61%), followed by pneumonia (4/18; 22%). Ten dogs (56%) had only 1 organ dysfunction, whereas 3 dogs (17%) had 2, 3 (17%) had 3, 1 (6%) had 4 and 1 (6%) had 5 organ dysfunctions. The median APPLE(FAST) score in the septic dogs was 28.5 (Q1-Q3, 24–31). Mean plasma concentrations of all endothelial and inflammatory biomarkers, except vWF, were higher in the sepsis cohort than in controls. The mean endothelial biomarker concentrations in the septic cohort ranged from ~2.7-fold higher for HA (difference in means; 118.2 ng/mL, 95% credible limit; 44.5–221.7) to ~150-fold for VEGF (difference in means; 76.6 pg./mL, 95% credible limit; 33.0–143.4), compared to the healthy cohort. Fifteen dogs with sepsis (83%) died; 7 (46%) were euthanized and 8 (53%) died during hospitalization. CONCLUSION: Dogs with naturally occurring sepsis and organ dysfunction had higher mean concentrations of biomarkers of endothelial activation and inflammation compared to healthy dogs, broadening our understanding of the pathophysiology of sepsis secondary to endothelial dysfunction.
format Online
Article
Text
id pubmed-10372490
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-103724902023-07-28 Biomarkers of endothelial activation and inflammation in dogs with organ dysfunction secondary to sepsis Gaudette, Sarah Smart, Lisa Woodward, Andrew P. Sharp, Claire R. Hughes, Dez Bailey, Simon R. Dandrieux, Julien R. S. Santos, Leilani Boller, Manuel Front Vet Sci Veterinary Science INTRODUCTION: Alteration in endothelial function during sepsis is thought to play a key role in the progression of organ failure. We herein compared plasma concentrations of endothelial activation biomarkers vascular endothelial growth factor (VEGF), hyaluronan (HA), plasminogen activator inhibitor-1 (PAI-1) and von Willebrand factor (vWF), as well as inflammatory mediator concentrations (IL-6, IL-8, IL-10, C-reactive protein and monocyte chemoattractant protein-1) in dogs with sepsis to healthy dogs. METHODS: This study was a multicenter observational clinical trial conducted at two university teaching hospitals from February 2016 until July 2017. The study included 18 client-owned dogs hospitalized with sepsis and at least one distant organ dysfunction, as well as 20 healthy dogs. Plasma biomarker concentrations were measured using ELISA. Severity of illness in dogs with sepsis was calculated using the 5-variable acute physiologic and laboratory evaluation (APPLE(FAST)) score. Biomarker concentrations were compared between septic and healthy dogs using linear models. RESULTS: Septic peritonitis was the most frequent source of sepsis (11/18; 61%), followed by pneumonia (4/18; 22%). Ten dogs (56%) had only 1 organ dysfunction, whereas 3 dogs (17%) had 2, 3 (17%) had 3, 1 (6%) had 4 and 1 (6%) had 5 organ dysfunctions. The median APPLE(FAST) score in the septic dogs was 28.5 (Q1-Q3, 24–31). Mean plasma concentrations of all endothelial and inflammatory biomarkers, except vWF, were higher in the sepsis cohort than in controls. The mean endothelial biomarker concentrations in the septic cohort ranged from ~2.7-fold higher for HA (difference in means; 118.2 ng/mL, 95% credible limit; 44.5–221.7) to ~150-fold for VEGF (difference in means; 76.6 pg./mL, 95% credible limit; 33.0–143.4), compared to the healthy cohort. Fifteen dogs with sepsis (83%) died; 7 (46%) were euthanized and 8 (53%) died during hospitalization. CONCLUSION: Dogs with naturally occurring sepsis and organ dysfunction had higher mean concentrations of biomarkers of endothelial activation and inflammation compared to healthy dogs, broadening our understanding of the pathophysiology of sepsis secondary to endothelial dysfunction. Frontiers Media S.A. 2023-07-13 /pmc/articles/PMC10372490/ /pubmed/37520007 http://dx.doi.org/10.3389/fvets.2023.1127099 Text en Copyright © 2023 Gaudette, Smart, Woodward, Sharp, Hughes, Bailey, Dandrieux, Santos and Boller. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Veterinary Science
Gaudette, Sarah
Smart, Lisa
Woodward, Andrew P.
Sharp, Claire R.
Hughes, Dez
Bailey, Simon R.
Dandrieux, Julien R. S.
Santos, Leilani
Boller, Manuel
Biomarkers of endothelial activation and inflammation in dogs with organ dysfunction secondary to sepsis
title Biomarkers of endothelial activation and inflammation in dogs with organ dysfunction secondary to sepsis
title_full Biomarkers of endothelial activation and inflammation in dogs with organ dysfunction secondary to sepsis
title_fullStr Biomarkers of endothelial activation and inflammation in dogs with organ dysfunction secondary to sepsis
title_full_unstemmed Biomarkers of endothelial activation and inflammation in dogs with organ dysfunction secondary to sepsis
title_short Biomarkers of endothelial activation and inflammation in dogs with organ dysfunction secondary to sepsis
title_sort biomarkers of endothelial activation and inflammation in dogs with organ dysfunction secondary to sepsis
topic Veterinary Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10372490/
https://www.ncbi.nlm.nih.gov/pubmed/37520007
http://dx.doi.org/10.3389/fvets.2023.1127099
work_keys_str_mv AT gaudettesarah biomarkersofendothelialactivationandinflammationindogswithorgandysfunctionsecondarytosepsis
AT smartlisa biomarkersofendothelialactivationandinflammationindogswithorgandysfunctionsecondarytosepsis
AT woodwardandrewp biomarkersofendothelialactivationandinflammationindogswithorgandysfunctionsecondarytosepsis
AT sharpclairer biomarkersofendothelialactivationandinflammationindogswithorgandysfunctionsecondarytosepsis
AT hughesdez biomarkersofendothelialactivationandinflammationindogswithorgandysfunctionsecondarytosepsis
AT baileysimonr biomarkersofendothelialactivationandinflammationindogswithorgandysfunctionsecondarytosepsis
AT dandrieuxjulienrs biomarkersofendothelialactivationandinflammationindogswithorgandysfunctionsecondarytosepsis
AT santosleilani biomarkersofendothelialactivationandinflammationindogswithorgandysfunctionsecondarytosepsis
AT bollermanuel biomarkersofendothelialactivationandinflammationindogswithorgandysfunctionsecondarytosepsis